(Q51748194)

11 April 2018

title

Oral delivery of glucagon like peptide-1 by a recombinant Lactococcus lactis. (English)

1 reference

11 April 2018

1 reference

Lactococcus lactis

1 reference

Payal Agarwal

1

1 reference

11 April 2018

Pulkit Khatri

2

1 reference

11 April 2018

Blasé Billack

3

1 reference

11 April 2018

Woon-Kai Low

4

1 reference

11 April 2018

Jun Shao

5

1 reference

11 April 2018

publication date

14 June 2014

1 reference

11 April 2018

published in

Pharmaceutical Research

1 reference

11 April 2018

volume

31

1 reference

11 April 2018

issue

12

1 reference

11 April 2018

page(s)

3404-3414

1 reference

11 April 2018

Control of glucose homeostasis by incretin hormones

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1430-3

The role of incretins in glucose homeostasis and diabetes treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1430-3

Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1430-3

The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1430-3

The glucagon-like peptides: a double-edged therapeutic sword?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1430-3

Dipeptidyl peptidase inhibitors as new drugs for the treatment of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1430-3

Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1430-3

Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1430-3

Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1430-3

Normal flora: living vehicles for non-invasive protein drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1430-3

Necrotising pneumonia caused by Lactococcus lactis cremoris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1430-3

Delivery of TEM beta-lactamase by gene-transformed Lactococcus lactis subsp. lactis through cervical cell monolayer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1430-3

Cell wall anchoring of the Streptococcus pyogenes M6 protein in various lactic acid bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1430-3

High level heterologous protein production in Lactococcus and Lactobacillus using a new secretion system based on the Lactobacillus brevis S-layer signals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1430-3

Signal peptide and propeptide optimization for heterologous protein secretion in Lactococcus lactis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1430-3

Probiotic properties of lactic-acid bacteria: plenty of scope for fundamental R & D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1430-3

A new cell surface proteinase: sequencing and analysis of the prtB gene from Lactobacillus delbruekii subsp. bulgaricus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1430-3

Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1430-3

Expression of the protective antigen of Bacillus anthracis by Lactobacillus casei: towards the development of an oral vaccine against anthrax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1430-3

Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1430-3

Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1430-3

Secretion of biologically active porcine interleukin-2 by Lactococcus lactis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1430-3

Enhanced secretion of biologically active murine interleukin-12 by Lactococcus lactis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1430-3

Improved cloning vectors and transformation procedure for Lactococcus lactis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1430-3

Transepithelial electrical resistance is not a reliable measurement of the Caco-2 monolayer integrity in Transwell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1430-3

Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1430-3

MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1430-3

The potential of chitosan for the oral administration of peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1430-3

Delivery systems for penetration enhancement of peptide and protein drugs: design considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1430-3

Strategies to improve oral drug bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1430-3

Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine

21 January 2018

1 reference

12 December 2020

Recombinant Lactobacillus johnsonii as a mucosal vaccine delivery vehicle

1 reference

12 December 2020

Oral delivery of beta-lactamase by Lactococcus lactis subsp. lactis transformed with Plasmid ss80

1 reference

12 December 2020

Secretion of biologically active murine interleukin-2 by Lactococcus lactis subsp. lactis

1 reference

12 December 2020

IMMUNOLOGY: Therapeutic Manipulation of Gut Flora

1 reference

12 December 2020

Liver abscess caused by Lactococcus lactis cremoris: a new pathogen

1 reference

12 December 2020

Prevalence of Escherichia coli O157:H7 and Performance by Beef Feedlot Cattle Given Lactobacillus Direct-Fed Microbials

1 reference

12 December 2020

Studies on the Passage of α-Chymotrypsin across the Intestine

1 reference

12 December 2020

Engineering the microflora to vaccinate the mucosa: serum immunoglobulin G responses and activated draining cervical lymph nodes following mucosal application of tetanus toxin fragment C-expressing lactobacilli

1 reference

12 December 2020

Genetic marking of Lactococcus lactis shows its survival in the human gastrointestinal tract.

1 reference

12 December 2020

A model of human small intestinal absorptive cells. 1. Transport barrier

1 reference

12 December 2020

On the role of the incretin hormones GIP and GLP-1 in the pathogenesis of Type 2 diabetes mellitus

1 reference

12 December 2020

Differential binding specificities of oral streptococcal antigen I/II family adhesins for human or bacterial ligands

1 reference

12 December 2020

Intranasal immunisation using recombinant Lactobacillus johnsonii as a new strategy to prevent allergic disease

1 reference

12 December 2020

Exenatide (Byetta) as a novel treatment option for type 2 diabetes mellitus

1 reference

12 December 2020

Isolation, selection, and characterization of lactic acid bacteria for a competitive exclusion product to reduce shedding of Escherichia coli O157:H7 in cattle.

1 reference

12 December 2020

10.1007/S11095-014-1430-3

Identifiers

DOI

1 reference

11 April 2018

1 reference

11 April 2018